Laying the foundation for Real-world evidence studies: a case study from Newfoundland and Labrador

Real-world evidence (RWE) studies are increasingly recognized for their potential to inform healthcare decisions. Prior research has shown that RWE can complement traditional clinical trial data by reflecting diverse patient populations and real-life treatment settings. However, the implementation of RWE projects often faces logistical and methodological challenges. No prior work had resolved the specific steps needed to establish a successful RWE partnership in a regional context. This gap motivated the creation of the Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP). The initiative seeks to explore how RWE can be effectively generated and applied in a local healthcare system. The focus on psoriatic disease in NL highlights the need for region-specific insights. Understanding the foundational elements of RWE projects is essential for broader adoption. This case study provides a framework for other jurisdictions to follow.

The purpose of the study was to outline the foundational elements required for a real-world evidence (RWE) project in Newfoundland and Labrador (NL). The study aimed to demonstrate how such a project could be executed effectively to support clinical decision-making. By focusing on psoriatic disease, the researchers sought to illustrate the practical application of RWE in a specific health context. The study also aimed to identify the key components necessary for successful RWE generation. These components include stakeholder engagement, data infrastructure, and policy alignment. The researchers proposed that the insights gained from this case study could be replicated in other regions. The ultimate goal was to improve health outcomes and healthcare delivery through RWE. This approach may provide a model for future RWE projects in similar settings.

The study used a case study approach to examine the Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) RWE project. The researchers analyzed the partnership structure and processes involved in generating real-world evidence. They focused on psoriatic disease as a model to illustrate the RWE framework. The study included an ongoing RWE project in NL to highlight practical implementation. The methods involved evaluating the collaboration between Janssen and local health authorities. The researchers described the data collection and analysis strategies employed. They also assessed the alignment of the project with regional healthcare goals. The findings were synthesized to identify key elements for successful RWE execution.

The study identified several foundational elements for successful real-world evidence (RWE) generation in Newfoundland and Labrador (NL). These included stakeholder collaboration, data infrastructure, and policy alignment. The ongoing psoriatic disease project demonstrated how RWE can inform clinical decisions and healthcare delivery. The partnership between Janssen and NL health authorities was a central component of the project. The researchers found that stakeholder engagement was crucial for project success. Data infrastructure was highlighted as a key enabler of RWE generation. The study also showed how RWE can support policy development. The results suggest that RWE projects can drive improvements in health outcomes. These findings may be applicable to other jurisdictions seeking to implement RWE initiatives.

The study concluded that the Janssen and Newfoundland and Labrador Health Innovation Partnership (JANL-HIP) RWE project provides a model for generating real-world evidence in a regional context. The researchers proposed that the foundational elements identified could be replicated in other jurisdictions. The study emphasized the importance of stakeholder collaboration in RWE projects. The findings suggest that RWE can support clinical decision-making and healthcare delivery. The researchers highlighted the role of data infrastructure in enabling RWE generation. They also noted the potential for RWE to influence policy development. The study may provide learning for future RWE projects in similar settings. These conclusions align with the authors' stated goals of improving health outcomes through RWE.